AE Wealth Management’s Enzo Biochem, Inc. ENZ Stock Holding History

AE Wealth Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$26K	–	2054
2023 Q4	$26K	Hold	20,000	–	–	﹤0.01%	2004
2023 Q3	$28K	Hold	20,000	–	–	﹤0.01%	1901
2023 Q2	$36.8K	Hold	20,000	–	–	﹤0.01%	1846
2023 Q1	$48.6K	Hold	20,000	–	–	﹤0.01%	1819
2022 Q4	$28.6K	Hold	20,000	–	–	﹤0.01%	1777
2022 Q3	$45K	Hold	20,000	–	–	﹤0.01%	1693
2022 Q2	$41K	Hold	20,000	–	–	﹤0.01%	1683
2022 Q1	$58K	Hold	20,000	–	–	﹤0.01%	1631
2021 Q4	$64K	Hold	20,000	–	–	﹤0.01%	1653
2021 Q3	$71K	Hold	20,000	–	–	﹤0.01%	1567
2021 Q2	$63K	Hold	20,000	–	–	﹤0.01%	1539
2021 Q1	$69K	Hold	20,000	–	–	﹤0.01%	1447
2020 Q4	$50K	Hold	20,000	–	–	﹤0.01%	1330
2020 Q3	$42K	Hold	20,000	–	–	﹤0.01%	1242
2020 Q2	$45K	Hold	20,000	–	–	﹤0.01%	1220
2020 Q1	$51K	Hold	20,000	–	–	﹤0.01%	1067
2019 Q4	$53K	Hold	20,000	–	–	﹤0.01%	1099
2019 Q3	$72K	Hold	20,000	–	–	﹤0.01%	958
2019 Q2	$67K	Hold	20,000	–	–	﹤0.01%	937
2019 Q1	$55K	Buy	+20,000	New	+$65.5K	﹤0.01%	624

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AE Wealth Management's ENZ Position: Q1 2024 in Review

AE Wealth Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2024, closing a stake of 20,000 shares — an estimated $26K sold.

AE Wealth Management first reported a position in ENZ in Q1 2019 and held it in 20 quarters. The position peaked at $72K in Q3 2019. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2024.

AE Wealth Management reported no remaining Enzo Biochem, Inc. position as of Q1 2024 after selling out during the quarter.
AE Wealth Management sold 20,000 Enzo Biochem, Inc. shares in Q1 2024, an estimated $26K.
AE Wealth Management first reported a position in Enzo Biochem, Inc. in Q1 2019 and held it in 20 quarters.
AE Wealth Management's Enzo Biochem, Inc. position peaked at $72K in Q3 2019.
41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2024.

Based on AE Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.